"""
PharmaTopicalFormulationCell — non-sterile topical (cream / gel / ointment) compounding.

Per ADR-2605250600 §Decision 2 (Wave 1b topical dosage form).

Pregel graph (5 nodes):

    receive_qc_attest             <-  pharma_qc emitted upstream (API + excipient lots)
        |
        v
    prepare_oil_phase             ->  white petrolatum + cetyl alcohol + mineral oil +
                                      cetomacrogol (per recipe); heat to 70-75°C jacket
        |
        v
    prepare_aqueous_phase         ->  water + propylene glycol + buffers + API dissolved
                                      or dispersed (per solubility); heat to match oil
        |
        v
    emulsify_and_cool             ->  add aqueous to oil under high-shear homogenizer;
                                      gradual cooling to 30-35°C with gentle agitation;
                                      viscosity check (cone-plate rheometer)
        |
        v
    fill_and_seal                 ->  aluminum tube (or HDPE jar) fill;
                                      crimping / cap sealing;
                                      in-process: weight, headspace, leak test
        |
        v
    emit_fill_finish_attest       ->  MST PUT com.etzhayyim.pharma.fillFinishAttestation
                                      with dosageForm = "topical-{cream|gel|ointment}"
                                      (sterility = "na" for intact-skin scope;
                                       microbial limit, viscosity, pH in qcAttestation)

Tier: B (Per-Domain).
Murakumo node (proposed): simeon (kuni-umi commissioning + container sibling).
Charter Rider §2(h) risk: clotrimazole 7-14 day use limit + diclofenac topical
photosensitivity / pregnancy 3rd-trimester warning. G11 enforcement = label scanner.
"""

from __future__ import annotations

# ─────────────────────────────────────────────────────────────────────────────
# COUNCIL ACTIVATION GATE
# ─────────────────────────────────────────────────────────────────────────────

COUNCIL_CHARTER_ATTESTATION_TX_HASH: str | None = None
SILEN_PHARMA_BASELINE_REVIEW_CID: str | None = None
QP_EQUIVALENT_REGISTRY_CID: str | None = None
TOPICAL_MIXER_EQUIPMENT_QUALIFICATION_CID: str | None = None
NON_STERILE_MICROBIAL_LIMIT_BASELINE_CID: str | None = None

if (
    COUNCIL_CHARTER_ATTESTATION_TX_HASH is None
    or SILEN_PHARMA_BASELINE_REVIEW_CID is None
    or QP_EQUIVALENT_REGISTRY_CID is None
    or TOPICAL_MIXER_EQUIPMENT_QUALIFICATION_CID is None
    or NON_STERILE_MICROBIAL_LIMIT_BASELINE_CID is None
):
    raise RuntimeError(
        "pharma_topical_formulation cell scaffold-only — Council has not "
        "attested (a) the yakushi master charter (G3), (b) the QP-equivalent "
        "registry (G4), (c) the topical mixer / homogenizer equipment "
        "qualification (Wave 1b silen-pharma-review trigger), or (d) the "
        "non-sterile microbial-limit baseline per ADR-2605250600 §Decision 3. "
        "Do not deploy."
    )


# Pregel super-step skeleton:
#
# class PharmaTopicalFormulationCell(PregelCell):
#     process_step = "topical-formulation"
#     pregel_tier = "B"
#     murakumo_node = "simeon"
#
#     def super_step(self, api_qc_attest, excipient_attests, formula_recipe):
#         # 1. validate API + excipient QC chains
#         # 2. prepare oil phase (70-75°C) + aqueous phase
#         # 3. emulsify under high-shear; cool with agitation
#         # 4. viscosity / pH in-process check
#         # 5. fill aluminum tube / HDPE jar; leak test
#         # 6. emit fillFinishAttestation with dosageForm = "topical-*"
#         raise NotImplementedError("R2+ phase wave implements super_step")
